Yahoo Web Search

Search results

    • Biotech Stocks Facing FDA Decision In June 2024

      RTT News· 3 hours ago

      Notably, in June, Eli Lilly's investigational antibody therapy Donanemab for treating early Alzheimer's will be reviewed by an advisory panel. Before delving into the drugs awaiting